Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam

被引：33
|
作者：
Jaruratanasirikul, Sutep [1 ]
Wongpoowarak, Wibul [2 ]
Aeinlang, Nanchanit [1 ]
Jullangkoon, Monchana [1 ]
机构：
[1] Prince Songkla Univ, Fac Med, Dept Med, Hat Yai, Songkla, Thailand
[2] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Hat Yai, Songkla, Thailand
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2013年 / 57卷 / 07期
关键词：
RESISTANT ACINETOBACTER-BAUMANNII; EFFICACY; ANTIBIOTICS; AMPICILLIN; PNEUMONIA; STRAINS; TISSUE;
D O I：
10.1128/AAC.00342-13
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The aim of this study was to reveal population pharmacokinetics and assess the efficacies of various dosage regimens of sulbactam in terms of the probability of target attainment with this agent over a range of MICs. Monte Carlo simulations were performed to determine the probability of attaining specific pharmacodynamic targets. The results indicated that a regimen consisting of a 4-h infusion of 3 g of sulbactam every 8 h would be an alternative treatment option for less-susceptible pathogens.
引用
收藏
页码：3441 / 3444
页数：4
相关论文
共 50 条
  • [21] Pharmacokinetics of ampicillin-sulbactam and the renal function-based optimization of dosing regimens for prophylaxis in patients undergoing cardiovascular surgery
    Yokoyama, Yuta
    Matsumoto, Kazuaki
    Yamamoto, Hiroyuki
    Iguro, Yoshifumi
    Imoto, Yutaka
    Ikawa, Kazuro
    Morikawa, Norifumi
    Ishida, Shiro
    Okano, Yoshiro
    Watanabe, Erika
    Shimodozono, Yoshihiro
    Yamada, Katsushi
    Takeda, Yasuo
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (06) : 878 - 882
  • [22] Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Dosage Regimens
    Zintzaras, Elias
    Dahabreh, Issa J.
    Giannouli, Stavroula
    Voulgarelis, Michael
    Moutsopoulos, Haralampos M.
    CLINICAL THERAPEUTICS, 2008, 30 (11) : 1939 - 1955
  • [23] In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii
    Housman, Seth T.
    Hagihara, Mao
    Nicolau, David P.
    Kuti, Joseph L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (10) : 2296 - 2304
  • [24] Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling
    Zhu, Shixing
    Zhang, Jiayuan
    Lv, Zhihua
    Zhu, Peijuan
    Oo, Charles
    Yu, Mingming
    Sy, Sherwin K. B.
    CLINICAL PHARMACOKINETICS, 2022, 61 (10) : 1427 - 1441
  • [25] Ultraviolet spectrophotometry (dual wavelength and chemometric) and high performance liquid chromatography for simultaneous estimation of meropenem and sulbactam sodium in pharmaceutical dosage form
    Marwada, Kuldip R.
    Patel, Jigar B.
    Patel, Nisarg S.
    Patel, Bhargav D.
    Borkhatariya, Dharnant V.
    Patel, Archita J.
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2014, 124 : 292 - 299
  • [26] Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals
    Arab-Alameddine, M.
    Lubomirov, R.
    Fayet-Mello, A.
    Aouri, M.
    Rotger, M.
    Buclin, T.
    Widmer, N.
    Gatri, M.
    Ledergerber, B.
    Rentsch, K.
    Cavassini, M.
    Panchaud, A.
    Guidi, M.
    Telenti, A.
    Decosterd, L. A.
    Csajka, C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2489 - 2498
  • [27] Different dosage regimens of Eptinezumab for the treatment of migraine: a meta-analysis from randomized controlled trials
    Yan, Zeya
    Xue, Tao
    Chen, Shujun
    Wu, Xin
    Yang, Xingyu
    Liu, Guangjie
    Gao, Shan
    Chen, Zhouqing
    Wang, Zhong
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01)
  • [28] Intratumoral Modeling of Gefitinib Pharmacokinetics and Pharmacodynamics in an Orthotopic Mouse Model of Glioblastoma
    Sharma, Jyoti
    Lv, Hua
    Gallo, James M.
    CANCER RESEARCH, 2013, 73 (16) : 5242 - 5252
  • [29] Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens
    Cheah, Soon-Ee
    Johnson, Matthew D.
    Zhu, Yan
    Tsuji, Brian T.
    Forrest, Alan
    Bulitta, Jurgen B.
    Boyce, John D.
    Nation, Roger L.
    Li, Jian
    SCIENTIFIC REPORTS, 2016, 6
  • [30] Semimechanistic Pharmacokinetic/Pharmacodynamic Modeling of Fosfomycin and Sulbactam Combination against Carbapenem-Resistant Acinetobacter baumannii
    Lim, Sazlyna Mohd Sazlly
    Heffernan, Aaron J.
    Roberts, Jason A.
    Sime, Fekade B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (05)
12345